​Mytos is a London-based biotechnology company specializing in automating human cell manufacturing for the pharmaceutical and biotech industries. Their flagship product, the iDEM™ system, fully automates the cultivation of various human cell types, including those derived from induced pluripotent stem cells (iPSCs), such as heart and brain cells.

By integrating advanced fluidics, imaging, and environmental controls, Mytos addresses common challenges in manual cell culture—such as contamination, variability, and labor intensity—thereby enhancing consistency and efficiency in cell production . This automation is particularly beneficial in drug discovery and regenerative medicine, where high-quality cell cultures are essential.​